drugset
drugset / Trial / NCT02634034

A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers

NCT02634034 ↗

Phase 1 Completed 18 enrolled Kowa Research Institute, Inc.
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to compare the pharmacokinetics and safety of a controlled release (CR) version of pitavastatin (also referred to as NK-104) to immediate release (IR) pitavastatin in healthy adult volunteers.

Timeline

Start
2015-12
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitavastatin Small molecule 4 mg —
Subject Pitavastatin Small molecule 8 mg —

Indications

hyperlipidemia